Endothelin Converting-Enzyme-1 mRNA Expression in Human Cardiovascular Disease

References

• Kashiwabara T, Inagaki Y, Ohta H, Iwamatsu A, Nomizu M, Morita A, et al. Putative precursors of endothelin have less vasoconstrictor activity in vitro but a potent pressor effect in vivo. FEBS Lett. 1989; 247: 73–76
   PubMed Web of Science ®Google Scholar
• Kimura S, Kasuya Y, Sawamura T, Shinimi O, Sugita Y, Yanagisawa M, et al. Conversion of big endothelin-1 to 21-residue endothelin-1 is essential for expression of full vasoconstrictor activity: structure-activity relationships of big endothelin-1. J Cardiovasc Pharmacol 1989; 13(Suppl 5)S5–7
   PubMedGoogle Scholar
• Berry J A, Burgess A J, Towers P. Scintillation proximity assay: competitive binding studies with [125I]endothelin-1 in human placenta and porcine lung. J Cardiovasc Pharmacol 1991; 17(Suppl 7)S143–5
   PubMedGoogle Scholar
• Howard P G, Plumpton C, Davenport A P. Anatomical localization and pharmacological activity of mature endothelins and their precursors in human vascular tissue. J Hypertens 1992; 10: 1379–1386
   PubMed Web of Science ®Google Scholar
• Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, et al. ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 1994; 78: 473–485
   PubMed Web of Science ®Google Scholar
• Komuro I, Kurihara H, Sugiyama T, Yoshizumi M, Takaku F, Yazaki Y. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells [published erratum appears in FEBS Lett 1989 Feb 27;244(2):509]. FEBS Lett. 1988; 238: 249–252
   PubMed Web of Science ®Google Scholar
• Takuwa Y, Yanagisawa M, Takuwa N, Masaki T. Endothelin, its diverse biological activities and mechanisms of action. Prog Growth Factor Res 1989; 1: 195–206
   PubMedGoogle Scholar
• Miyasaka N, Hirata Y, Ando K, Sato K, Morita H, Shichiri M, et al. Increased production of endothelin-1 in patients with inflammatory arthritides. Arthritis Rheum 1992; 35: 397–400
   PubMed Web of Science ®Google Scholar
• Noveral J P, Rosenberg S M, Anbar R A, Pawlowski N A, Grunstein M M. Role of endothelin-1 in regulating proliferation of cultured rabbit airway smooth muscle cells. Am J Physiol 1992; 263: L317–24
   PubMed Web of Science ®Google Scholar
• Luscher T F. Endothelium in the control of vascular tone and growth: role of local mediators and mechanical forces. Blood Press Suppl 1994; 1: 18–22
   PubMedGoogle Scholar
• Simonson M S, Dunn M J. Cellular signaling by peptides of the endothelin gene family. FASEB J. 1990; 4: 2989–3000
   PubMed Web of Science ®Google Scholar
• Hahn A W, Resink T J, Scott Burden T, Powell J, Dohi Y, Buhler F R. Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. Cell Regul 1990; 1: 649–659
   PubMedGoogle Scholar
• Weber K T, Anversa P, Armstrong P W, Brilla C G, Burnett J C, Jr., Cruickshank J M, et al. Remodeling and reparation of the cardiovascular system. J Am Coll Cardiol 1992; 20: 3–16
   PubMed Web of Science ®Google Scholar
• Battistini B, Chailler P, D'Orleans Juste P, Briere N, Sirois P. Growth regulatory properties of endothelins. Peptides 1993; 14: 385–399
   PubMed Web of Science ®Google Scholar
• Shi S J, Rakugi H, Higashimori K, Jiang B B, Higaki J, Mikami H, et al. Augmentation by converting enzyme inhibition of accelerated endothelin release from rat mesenteric arteries following nephrectomy. Biochem Biophys Res Commun 1994; 202: 246–251
   PubMed Web of Science ®Google Scholar
• Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156–159
   PubMed Web of Science ®Google Scholar
• Hughes M JG, Andrews D W. Creation of deletion, insertion and substitution mutations using a single pair of primers and PCR. Biotechniques 1996; 20: 188–196
   PubMed Web of Science ®Google Scholar
• Gilliland G, Perrin S, Blanchard K, Bunn H F. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sci USA 1990; 87: 2725–2729
   PubMed Web of Science ®Google Scholar
• Miyauchi T, Yanagisawa M, Tomizawa T, Sugishita Y, Suzuki N, Fujino M, et al. Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction [letter]. Lancet 1989; 2: 53–54
   PubMed Web of Science ®Google Scholar
• Kusumoto K, Awane Y, Fujiwara S, Watanabe T. Role of endogenous endothelin in extension of rabbit myocardial infarction. J Cardiovasc Pharmacol 1993; 22(Suppl 8)S339–342
   PubMedGoogle Scholar
• Lechleitner P, Genser N, Mair J, Maier J, Artner Dworzak E, Dienstl F, et al. Endothelin-1 in patients with complicated and uncomplicated myocardial infarction. Clin Investig 1992; 70: 1070–1072
   PubMedGoogle Scholar
• Tomoda H. Plasma endothelin-1 in acute myocardial infarction with heart failure. Am Heart J 1993; 125: 667–672
   PubMed Web of Science ®Google Scholar
• Omland T, Lie R T, Aakvaag A, Aarsland T, Dickstein K. Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation 1994; 89: 1573–1579
   PubMed Web of Science ®Google Scholar
• Ray S G, McMurray J J, Morton J J, Dargie H J. Circulating endothelin in acute ischaemic syndromes. Br Heart J 1992; 67: 383–386
   PubMedGoogle Scholar
• Feron O, Salomone S, Godfraind T h. Action of the calcium channel blocker lacidipine on cardiac hypertrophy and endothelin-1 gene expression in strokeprone hypertensive rats. Br J Pharmacol 1996; 118: 659–664
   PubMed Web of Science ®Google Scholar
• Krum H, Gu A, Wilshire-Clement M, Sackner-Bernstein J, Goldsmith R, Medina N, Yushak M, Miller M, Packer M. Changes in plasma endothelin-1 levels reflect clinical response to β-blockade in chronic heart failure. Am Heart J 1996; 131: 337–341
   PubMed Web of Science ®Google Scholar
• Hendricks-Munoz K D, Gerrets R P, Higgins R D, Munoz J L, Caines V V. Cocaine-stimulated endothelin-1 release is decreased by angiotensin-converting enzyme inhibitors in cultured endothelial cells. Cardiovasc Res 1996; 31: 117–123
   PubMed Web of Science ®Google Scholar
• Abernethy D R, Laurie N, Andrawis N S. Local angiotensin-converting enzyme inhibition blunts endothelin-1-induced increase in forearm vascular resistance. Clin Pharmacol Ther 1995; 58: 328–334
   PubMed Web of Science ®Google Scholar
• Wang X, Douglas S A, Feuerstein G Z, Ohlstein E H. Temporal expression of ECE-1, ET-1, ET-3, ETA, and ETB receptor mRNAs after balloon angioplasty in the rat. J Cardiovasc Pharmacol 1995; 26(Suppl 3)S22–5
   PubMedGoogle Scholar
• Kurihara T, Kurihara H, Takahashi M, Shimada K, Maemura K, Oda H, Ishikawa T, Uchiyama T, Tanzawa K, Yazaki Y. Endothelin-converting enzyme expression in the rat vascular injury model and hu man athorosclerosis. Circulation 1997; 95: 221–230
   PubMed Web of Science ®Google Scholar
• Yorikane R, Sakai S, Miyauchi T, Sakurai T, Goto K. Increased production of endothelin-1 in the hypertrophied rat heart due to pressure overload. FEBS-Lett. 1993; 332(1–2)31–4
   PubMed Web of Science ®Google Scholar